• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hemorrhagic Fever

Hemorrhagic Fever - 27 Studies Found

Enrolling by invitation : Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
: Viral Hemorrhagic Fever
: 2015-06-24
: Drug: Ribavirin
  • Loading do
  • Active, not recruiting : Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
    : Crimean-Congo Hemorrhagic Fever
    : 2017-01-11
    :
    • Biological: KIRIM-KONGO-VAX Cr

    Enrolling by invitation : Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
    :
    • Crimean-Congo Hemorrhagic Fever
    • Lassa Fever

    : 2009-10-08
    : Drug: Ribavirin (Virazole) Injection The drug is to be adm
    Active, not recruiting : Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
    : Hemorrhagic Fever, Ebola
    : 2015-01-29
    :
    • Biological: cAd3-EBOZ cAd3 vac

    Completed : Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
    : Ebola Hemorrhagic Fever
    : 2016-09-14
    : Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
    Completed : Open Study of the Duration of Immunity After Vaccination With GamEvac
    : Hemorrhagic Fever, Ebola
    : 2016-09-14
    : Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
    Completed : Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
    : Hemorrhagic Fever, Ebola
    : 2015-11-04
    :
    • Biological: Ad26.ZEBOV One 0.5

    Completed : Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
    : Hemorrhagic Fever, Ebola
    : 2016-01-08
    :
    • Biological: Ad26.ZEBOV No vacc

    Withdrawn : A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
    : Ebola Hemorrhagic Fever
    : 2012-05-03
    :
    • Drug: AVI-7537

    Completed : Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
    : Ebola Hemorrhagic Fever
    : 2011-05-10
    :
    • Drug: Placebo Normal saline

    Next >>>
    Orthopedics Health
    Orthopedics Health WebHealth Network Media
    • WebHealthNetwork
    • DiabetesHealthMatters
    • HeartandStrokeHealth
    • WomensHealthCareCommunity
    • AsthmaHealthCenter
    • CancerHealthCenter
    • MentalHealthHelpCenter
    • Skincarehealthcenter
    • DigestiveTractHealth
    • VaccineHealthCenter
    • PainHealthCenter
    • FightingAddictionCenter
    • ObesityHealthMatters
    • SeniorHealthcareMatters
    • BrainAndNerveCenter
    • PediatricsHealthCenter
    • RareDiseasesHealthCenter
    • Wealth Mason
    • Home Owners Circle
    • EasyInsuranceFinder
    • EduJumpStart
    • SaleSpider
    • ScoopCafe
    • SaleSpiderMedia
    • Viewpoint.World
    • TravelerBooked
    • TechNewsBytes
    • Contact Us
    • Advertising Privacy Policy

    This site uses cookies for analytics and advertising. No personal information is collected.

    © Orthopedics Health .

    We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.